Motus GI Holdings, Inc. (MOTS)
Stock Price:
$0.760 USD
0.005 (0.66%)
Updated Oct 30, 2020 10:37 AM EDT - Market open
Key Info
| Market Cap |
24.46M |
| Revenue (ttm) |
131,000 |
| Net Income (ttm) |
-22.05M |
| Shares Out |
32.18M |
| EPS (ttm) |
-0.77 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Oct 30, 2020 |
| Last Price |
$0.760 |
| Previous Close |
$0.755 |
| Change ($) |
0.005 |
| Change (%) |
0.66% |
| Day's Open |
0.775 |
| Day's Range |
0.742 - 0.775 |
| Day's Volume |
31,875 |
| 52-Week Range |
0.460 - 2.850 |
More Stats
| Market Cap |
24.46M |
| Enterprise Value |
16.21M |
| Earnings Date (est) |
Nov 12, 2020 |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
32.18M |
| Float |
27.48M |
| EPS (basic) |
-0.76 |
| EPS (diluted) |
-0.77 |
| FCF / Share |
-0.76 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
464,193 |
| Short Ratio |
4.94 |
| Short % of Float |
1.69% |
| Beta |
2.74 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
186.71 |
| PB Ratio |
2.81 |
| Revenue |
131,000 |
| Operating Income |
-22.36M |
| Net Income |
-22.05M |
| Free Cash Flow |
-22.02M |
| Net Cash |
8.25M |
| Net Cash / Share |
0.26 |
| Gross Margin |
-22.14% |
| Operating Margin |
-17,070.99% |
| Profit Margin |
-16,834.40% |
| FCF Margin |
-16,809.16% |
| ROA |
-78.57% |
| ROE |
-259.74% |
| ROIC |
-341.30% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Forecasts
Analyst Ratings (6)
| Buy |
6 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
Price Target
$2.81*
(269.74% upside)
Low
2.50
Current: $0.760
High
3.00
Target: 2.81
*Average 12-month price target from 6 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 |
|---|
| Revenue | 0.11 | 0.04 | - | - |
| Revenue Growth | 197.22% | - | - | - |
| Gross Profit | -0.03 | -0.02 | - | - |
| Operating Income | -23.44 | -18.93 | -12.96 | -6.01 |
| Net Income | -23.09 | -22.26 | -13.20 | -8.02 |
| Shares Outstanding | 25.13 | 15.14 | 10.33 | 1.15 |
| Earnings Per Share | -0.92 | -1.47 | -1.28 | -7.00 |
| Operating Cash Flow | -19.92 | -14.93 | -10.40 | -6.13 |
| Capital Expenditures | -0.47 | -0.55 | -0.71 | -0.03 |
| Free Cash Flow | -20.38 | -15.48 | -11.11 | -6.16 |
| Cash & Equivalents | 28.73 | 21.09 | 6.94 | 11.64 |
| Total Debt | 8.79 | - | - | - |
| Net Cash / Debt | 19.94 | 21.09 | 6.94 | 11.64 |
| Assets | 32.26 | 22.95 | 9.17 | 12.19 |
| Liabilities | 13.93 | 4.44 | 3.65 | 2.16 |
| Book Value | 18.33 | 18.52 | 5.52 | 10.03 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Motus GI Holdings, Inc. |
| Country |
United States |
| Employees |
49 |
| CEO |
Timothy P. Moran |
Stock Information
| Ticker Symbol |
MOTS |
| Stock Exchange |
NASDAQ |
| Sector |
Healthcare |
| Industry |
Diagnostics & Research |
| Unique Identifier |
NASDAQ: MOTS |
| IPO Date |
February 14, 2018 |
Description
Motus GI Holdings, a medical technology company, provides endoscopy solutions that enhance clinical outcomes and the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions in the United States and Israel. Its flagship product is the Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. The company is based in Fort Lauderdale, Florida.